Streetbeat News

Corporate Responsibility

SEOVF

Sernova Biotherapeutics has appointed Dr. Pericles Calias as Chief Development Officer and Head of R&D. Dr. Calias is expected to bring operational depth and cell therapy expertise to the company.

Portfolio Pulse from

March 10, 2025 | 12:15 pm

GAMI

Gabelli Funds has opened a new office in Zurich, Switzerland, to expand its global research capabilities. This new location will complement their existing offices in London, Tokyo, and Shanghai.

Portfolio Pulse from

March 10, 2025 | 12:15 pm

BL

BlackLine, Inc. has entered into a cooperation agreement with Scalar Gauge Fund to appoint Scott Davidson as a new independent member of its Board of Directors by March 14, 2025.

Portfolio Pulse from

March 10, 2025 | 12:15 pm

RMR

SVC

Service Properties Trust (SVC) has appointed Chris Bilotto as Managing Trustee, President, and CEO, effective March 10, 2025. Bilotto is currently an EVP at The RMR Group, overseeing acquisitions and asset management.

Portfolio Pulse from

March 10, 2025 | 12:15 pm

BASFY

BASF has introduced the world's first biomass-balanced polyethersulfone, enhancing transparency for its Ultrason customers by sharing Product Carbon Footprint (PCF) data. This allows customers to better assess the environmental impact of their products.

Portfolio Pulse from

March 10, 2025 | 12:00 pm

FCN

FTI Consulting, Inc. has appointed Dr. Mary T. Coleman as the Head of the U.S. Antitrust practice at its Compass Lexecon subsidiary.

Portfolio Pulse from

March 10, 2025 | 11:45 am

OPRX

OptimizeRx Corporation has appointed Stephen Silvestro as its new Chief Executive Officer. Silvestro is known for his ability to accelerate revenue growth, enhance brand relevance, and build strong teams.

Portfolio Pulse from

March 10, 2025 | 11:45 am

GOOG

The Department of Justice (DOJ) has decided to drop its effort to force Google to sell its AI company. This decision could have implications for Google's business strategy and its position in the AI market.

Portfolio Pulse from

March 10, 2025 | 11:45 am

NLSP

NLS Pharmaceutics Ltd., a Swiss clinical-stage biopharmaceutical company, issued a letter to its shareholders. The company is focused on developing therapies for CNS disorders.

Portfolio Pulse from

March 10, 2025 | 11:15 am

NRBAY

The article announces the ordinary general meeting of the investment association Nordea Invest, scheduled for April 7, 2025.

Portfolio Pulse from

March 10, 2025 | 11:15 am